HRA Pharma Reveals Big Growth Ambitions In Quest To Become Top-10 OTC Player

12 Dec 2018

A combination of prescription-to-OTC switches, acquisitions and maximising the potential of its existing portfolio will take France’s HRA Pharma to the next level, reveals chief commercial officer Martyn Hilton.

HRA Pharma's Martyn Hilton • Source: Mark Earthy

HRA Pharma Reveals Big Growth Ambitions In Quest To Become Top-10 OTC Player

More from Strategy

More from Business